Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fed Male.
NCT02417844 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 34
Last updated 2020-04-17
Summary
Two tamsulosin HClformulations will be tested in fed state
Conditions
- Prostatic Hyperplasia
Interventions
- DRUG
-
tamsulosin (Astellas)
- DRUG
-
Tamsulosin HCL
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Boehringer Ingelheim · Boehringer Ingelheim
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 64 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-04-30
- Primary Completion
- 2015-05-31
- Completion
- 2015-05-31
More Related Trials
-
A Study To Compare 3 Different Formulations Of Tamsulosin At Steady State.
NCT00609596 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate the Effect of Paroxetine Mediated CYP2D6 Inhibition on the Pharmacokinetics of Tamsulosin in Healthy Male Volunteers
NCT02264184 ·Status: COMPLETED ·Phase: PHASE1
-
Comparative Bioavailability of Two Fixed Dose Combination (FDC) Formulations of Dutasteride and Tamsulosin Hydrochloride Relative to Co-administration of Dutasteride With Tamsulosin Hydrochloride in Healthy Male Subjects Under Fed and Fasted States
NCT02184585 ·Status: COMPLETED ·Phase: PHASE1
-
FLOMAX® Versus HYTRIN® in Patients With the Signs and Symptoms of Benign Prostatic Hyperplasia
NCT02244255 ·Status: COMPLETED ·Phase: PHASE4
-
A Study With Combination Treatment (Tamsulosin Hydrochloride and Solifenacin Succinate) in Male Patients With LUTS/BPH
NCT00510406 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Determine the Bioavailability of a Fixed Dose Combination Product of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) Relative to Co-administration of the Individual Components in Healthy Male Subjects of North East Asian and Non-Asian Ancestry.
NCT01254071 ·Status: COMPLETED ·Phase: PHASE1
-
Actual Use Study of Tamsulosin in Men
NCT02573311 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Clinical Efficacy and Safety of Tamsulosin Alone or in Combination With Solifenacin for the Treatment in Men With Lower Urinary Tract Symptoms Including Overactive Bladder Symptoms
NCT02715024 ·Status: COMPLETED ·Phase: PHASE4
-
Bioequivalence Study of the Second Generation Dutasteride and Tamsulosin Hydrochloride (HCL) Combination Capsule in Fasted State
NCT02052713 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability Study of Fixed Dose Combination (FDC) Dutasteride and Tamsulosin Hydrochloride (HCl) Relative to One Dutasteride and One Tamsulosin HCl Tablet in Healthy Male Subjects
NCT02509104 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study of the Second Generation Dutasteride and Tamsulosin HCl Combination Capsule in Fed State
NCT02058576 ·Status: COMPLETED ·Phase: PHASE1
-
(Phosphodiesterase 5 Inhibitors & α-blockers): Single Versus Combined Therapy in Benign Prostatic Hyperplasia
NCT05236634 ·Status: UNKNOWN ·Phase: NA
-
Observational Study in Patients With Functional Benign Prostatic Hyperplasia Symptoms Who Switched From Phytotherapy to ALNA® (Tamsulosin)
NCT02244320 ·Status: COMPLETED
-
Study to Investigate the Effect of Ketoconazole Mediated CYP3A4 Inhibition on Pharmacokinetics of Tamsulosin in Healthy Male Volunteers
NCT02264171 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Tadalafil in Men With Benign Prostatic Hyperplasia
NCT00970632 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Characterise the Effect of Tamsulosin on Lower Urinary Tract Symptoms (LUTS) and Detrusor Motor Activity in Patients Affected by Benign Prostatic Hyperplasia (BPH) and Storage Urinary Symptoms
NCT02245490 ·Status: COMPLETED ·Phase: PHASE4
-
Tamsulosin Hydrochloride 0.4 mg Capsules Under Fed Conditions
NCT01149733 ·Status: COMPLETED ·Phase: PHASE1
-
Long Term Study of Solifenacin Succinate and Tamsulosin Hydrochloride Oral Controlled Absorption System (OCAS) in Males With Lower Urinary Tract Symptoms
NCT01021332 ·Status: COMPLETED ·Phase: PHASE3
-
FLOMAX® Versus Placebo, in Male Patients With Acute Urinary Retention Related to Benign Prostatic Hyperplasia (BPH)
NCT02244294 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Solifenacin and Tamsulosin
NCT02180997 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence - Duodart Against Avodart & Omnic
NCT01657851 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Tadalafil in Benign Prostatic Hyperplasia
NCT01183650 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Compare Giving AVODART And FLOMAX Together Or In A Combination Capsule In The Fed And Fasted State
NCT00537654 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Tolerability and Efficacy of Tamsulosin 0.4mg OCAS Formulation in Patients Who Are Unsatisfied With the Treatment of Tamsulosin 0.2mg Conventional Formulation
NCT02180789 ·Status: COMPLETED ·Phase: PHASE4
-
Pilot Study Investigating Safety and Efficacy of Tadalafil as Treatment for Benign Prostatic Hyperplasia (BPH) in Asian Men
NCT00540124 ·Status: COMPLETED ·Phase: PHASE2